We are delighted to announce funding from web3 powerhouse VCs Pantera Capital and Modular Capital
We have spent 5 years building out our secure, decentralized, incentivised genomics platform
Now is the time to scale up our data acquisition to make Genomes.io the
Some $GENE tokenomics
For each whole genome sequencing test we sell, we burn a set amount of GENE
This incentivizes #pharma companies to buy GENE. Early adopters have more query power as the fixed supply of 1 billion #GENE decreases over time.
genomes.gitbook.io/genomes.io-doc…
Team Genomes Partners with #Bittensor to pave the way for ethical, scaleable research in drug response & personalised medicine. 🧬
A #DeSci future is here. Join us!!
$GENOME$TAO
👇 👇
$GENOME & $TAO
‘Together with Bittensor, we’re paving the way for ethical, scalable research in drug response and personalized medicine, and we’re thrilled to have you follow along on this journey.’ 🧬
#DeSci#DeAI
👇 👇
$GENOME & $TAO
We are rapidly advancing with the development of our Bittensor Subnet for Human Genomics. 🧬
Listen in to this Space with the team at @opentensor how our mutual plans for building a Subnet came together and what we intend to do with in the future! 🚀
👇 👇
$GENOME & $TAO
‘Our first use case is Drug Response Prediction. By generating synthetic genomic profiles that mimic known variations in drug metabolism, we’re building models that estimate how we respond to medications’🧬
#DeSci#DeAi
👇 👇